Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tranexamic acid prophylaxis for bleeding severity in inherited platelet dysfunction
IRCT20200812048378N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in hereditary platelet function disorder (IPFD) comparing Tranexamic acid prophylaxis with Placebo (2 arms). Primary endpoints: Severity of bleeding, Number of bleeding episodes and 8 more. Started Aug 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hereditary platelet function disorder (IPFD)
Beyond the preview
Go deeper on IRCT20200812048378N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200812048378N1.